Fernando Carnicer

1.3k total citations
31 papers, 807 citations indexed

About

Fernando Carnicer is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Fernando Carnicer has authored 31 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 21 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Fernando Carnicer's work include Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (14 papers) and Hepatitis C virus research (13 papers). Fernando Carnicer is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (14 papers) and Hepatitis C virus research (13 papers). Fernando Carnicer collaborates with scholars based in Spain, United States and Italy. Fernando Carnicer's co-authors include Sonia Pascual, Pedro Zapater, Miguel Pérez‐Mateo, José M. Such, José M. Palazón, Rubén Francés, Francisco Uceda, Carlos Muñoz, Juan Antonio Casellas and Ana Cifuentes and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Hepatology.

In The Last Decade

Fernando Carnicer

29 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando Carnicer Spain 16 600 564 158 103 91 31 807
Nasser Mousa Egypt 15 385 0.6× 473 0.8× 201 1.3× 77 0.7× 62 0.7× 52 710
Amir Houshang Mohammad Alizadeh Iran 16 406 0.7× 438 0.8× 184 1.2× 67 0.7× 39 0.4× 41 762
Ahmed Abdel‐Razik Egypt 15 380 0.6× 492 0.9× 227 1.4× 71 0.7× 75 0.8× 43 715
H Schwacha Germany 12 268 0.4× 324 0.6× 304 1.9× 63 0.6× 110 1.2× 24 689
Naichaya Chamroonkul Thailand 14 345 0.6× 454 0.8× 116 0.7× 55 0.5× 43 0.5× 51 682
Camelia Cojocariu Romania 15 264 0.4× 401 0.7× 260 1.6× 96 0.9× 67 0.7× 78 754
Kilian Weigand Germany 14 345 0.6× 340 0.6× 182 1.2× 50 0.5× 68 0.7× 59 684
C. Fernández‐Gutiérrez Spain 13 208 0.3× 262 0.5× 80 0.5× 98 1.0× 35 0.4× 33 510
Jin Ding China 14 237 0.4× 251 0.4× 220 1.4× 70 0.7× 85 0.9× 35 746
Claudio Rodríguez-Ramos Spain 10 211 0.4× 222 0.4× 122 0.8× 76 0.7× 34 0.4× 12 402

Countries citing papers authored by Fernando Carnicer

Since Specialization
Citations

This map shows the geographic impact of Fernando Carnicer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Carnicer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Carnicer more than expected).

Fields of papers citing papers by Fernando Carnicer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Carnicer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Carnicer. The network helps show where Fernando Carnicer may publish in the future.

Co-authorship network of co-authors of Fernando Carnicer

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Carnicer. A scholar is included among the top collaborators of Fernando Carnicer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Carnicer. Fernando Carnicer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Martinez, Irma, Rubén Francés, José M. González‐Navajas, et al.. (2018). Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterialDNAin patients with cirrhosis. Liver International. 38(12). 2219–2227. 16 indexed citations
2.
Arenas, María Dolores, et al.. (2015). Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population. Kidney & Blood Pressure Research. 40(3). 258–265. 11 indexed citations
3.
de‐Madaria, Enrique, José María Palazón, José Sánchez–Payá, et al.. (2010). Acute and chronic hemodynamic changes after propranolol in patients with cirrhosis under primary and secondary prophylaxis of variceal bleeding: a pilot study. European Journal of Gastroenterology & Hepatology. 22(5). 507–512. 10 indexed citations
4.
Cuevas, José M., Manuela Torres‐Puente, Nuria Jiménez‐Hernández, et al.. (2009). Combined therapy of interferon plus ribavirin promotes multiple adaptive solutions in hepatitis C virus. Journal of Medical Virology. 81(4). 650–656. 6 indexed citations
5.
Cuevas, José M., Manuela Torres‐Puente, Nuria Jiménez‐Hernández, et al.. (2008). Refined analysis of genetic variability parameters in hepatitis C virus and the ability to predict antiviral treatment response. Journal of Viral Hepatitis. 15(8). 578–590. 15 indexed citations
6.
Pascual, Sonia, Javier Irurzun, Pedro Zapater, et al.. (2008). Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice. Liver International. 28(5). 682–689. 30 indexed citations
7.
Torres‐Puente, Manuela, José M. Cuevas, Nuria Jiménez‐Hernández, et al.. (2007). Genetic variability in hepatitis C virus and its role in antiviral treatment response. Journal of Viral Hepatitis. 15(3). 188–199. 25 indexed citations
8.
Buti, Marı́a, Francisco Rodríguez‐Frias, José Luís Calleja, et al.. (2007). Programa de uso compasivo con adefovir dipivoxil en España: valoración de su eficacia y estudio de las resistencias. Medicina Clínica. 129(15). 566–570.
9.
Torres‐Puente, Manuela, José M. Cuevas, Nuria Jiménez‐Hernández, et al.. (2007). Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment. Journal of Medical Virology. 80(2). 247–253. 14 indexed citations
10.
Torres‐Puente, Manuela, José M. Cuevas, Nuria Jiménez‐Hernández, et al.. (2007). Using evolutionary tools to refine the new hypervariable region 3 within the envelope 2 protein of hepatitis C virus. Infection Genetics and Evolution. 8(1). 74–82. 16 indexed citations
11.
Jiménez‐Hernández, Nuria, Vicente Sentandreu, Castro Ja, et al.. (2007). Effect of antiviral treatment and host susceptibility on positive selection in hepatitis C virus (HCV). Virus Research. 131(2). 224–232.
12.
Arenas, María Dolores, Guillermina Barril, Juan Manuel Buades, et al.. (2007). Anemia associated with pegylated interferon-?2a and ?2b therapy in hemodialysis patients. Clinical Nephrology. 67(6). 366–373. 22 indexed citations
13.
Pascual, Sonia, Pedro Zapater, José M. Such, et al.. (2006). Comparison of staging systems to predict survival in hepatocellular carcinoma. Liver International. 26(6). 673–679. 18 indexed citations
14.
Palazón, José M., José M. Such, José Sánchez–Payá, et al.. (2006). A comparison of two different dosages of somatostatin combined with sclerotherapy for the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Revista Española de Enfermedades Digestivas. 98(4). 249–54. 3 indexed citations
15.
Carnicer, Fernando, et al.. (2005). Treatment with pegylated interferon alpha 2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin. Revista Española de Enfermedades Digestivas. 97(5). 306–16. 3 indexed citations
16.
Zapater, Pedro, J.F. Horga, José M. Such, et al.. (2004). Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status. Alimentary Pharmacology & Therapeutics. 20(1). 29–36. 37 indexed citations
17.
Francés, Rubén, Susana Benlloch, Pedro Zapater, et al.. (2004). A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. Hepatology. 39(2). 484–491. 121 indexed citations
18.
Pascual, Sonia, P Griñó, Marı́a Niveiro, et al.. (2003). Etiología de la hemorragia digestiva alta de origen péptico: papel de Helicobacter pylori y los antiinflamatorios no esteroideos. Gastroenterología y Hepatología. 26(10). 630–634. 5 indexed citations
19.
Morales, Carmen E., et al.. (2002). Ileítis con ascitis de curso recurrente. Revista Clínica Española. 202(1). 37–38. 3 indexed citations
20.
Aparicio, José Ramón, José M. Such, Sonia Pascual, et al.. (1999). Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. Journal of Hepatology. 31(2). 277–283. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nasser Mousa Breakdown of academic impact, for papers by Amir Houshang Mohammad Alizadeh Breakdown of academic impact, for papers by Ahmed Abdel‐Razik Breakdown of academic impact, for papers by H Schwacha Breakdown of academic impact, for papers by Naichaya Chamroonkul Breakdown of academic impact, for papers by Camelia Cojocariu Breakdown of academic impact, for papers by Kilian Weigand Breakdown of academic impact, for papers by C. Fernández‐Gutiérrez Breakdown of academic impact, for papers by Jin Ding Breakdown of academic impact, for papers by Claudio Rodríguez-Ramos
Rankless by CCL
2026